🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

15+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 15 of 15 recruiting trials for “idiopathic-steroid-resistant-nephrotic-syndrome”

Phase 2RecruitingNCT06664814 ↗

An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomerulosclerosis

👨‍⚕️ William A Gahl, M.D., National Human Genome Research Institute (NHGRI)📍 1 site📅 Started Apr 2026View details ↗
Phase 3RecruitingNCT07220083 ↗

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

🏥 Boehringer Ingelheim📍 243 sites📅 Started Feb 2026View details ↗
Phase 2RecruitingNCT07268638 ↗

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

🏥 Akebia Therapeutics📍 8 sites📅 Started Dec 2025View details ↗
RecruitingNCT06820866 ↗

Non-invasive Diagnosis of Idiopathic Nephrotic Syndromes

👨‍⚕️ Alexandre LAHENS, Dr, Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started Apr 2025View details ↗
Phase 2RecruitingNCT06500702 ↗

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

🏥 Sanofi📍 70 sites📅 Started Dec 2024View details ↗
Phase 3RecruitingNCT06635720 ↗

REduced-dose Steroid PrOtocol for Childhood Nephrotic SyndromE (RESPONSE)

👨‍⚕️ Rulan Parekh, MD MS, The Hospital for Sick Children📍 1 site📅 Started Nov 2024View details ↗
RecruitingNCT06334692 ↗

Autoantibodies Against-nephrin in Idiopathic Nephrotic Syndrome

👨‍⚕️ Giuseppe Remuzzi, MD, Istituto Di Ricerche Farmacologiche Mario Negri📍 1 site📅 Started Mar 2024View details ↗
Phase 1, PHASE2RecruitingNCT06090227 ↗

AMPK-activation by Metformin in FSGS: AMP-FSGS

👨‍⚕️ Madhav Menon, MD, Yale University📍 2 sites📅 Started Dec 2023View details ↗
RecruitingNCT06162546 ↗

ARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and Biobank

🏥 Christoph Aufricht📍 1 site📅 Started Jan 2023View details ↗
RecruitingNCT05650619 ↗

Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease

👨‍⚕️ Eloise Salmon, MD, University of Michigan📍 1 site📅 Started Dec 2022View details ↗
Phase 3RecruitingNCT05183646 ↗

A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB

👨‍⚕️ David Fuller, Dimerix Bioscience Pty Ltd📍 220 sites📅 Started May 2022View details ↗
RecruitingNCT04207580 ↗

A National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood.

👨‍⚕️ Vincent Guigonis, MD, University Hospital, Limoges📍 48 sites📅 Started Mar 2020View details ↗
NARecruitingNCT04065438 ↗

Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System

🏥 Kaneka Medical America LLC📍 10 sites📅 Started Jan 2020View details ↗
NARecruitingNCT02235857 ↗

Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

👨‍⚕️ Jeffrey I Silberzweig, MD, Weill Medical College of Cornell University📍 12 sites📅 Started May 2015View details ↗
RecruitingNCT01605266 ↗

INSIGHT (Insight Into Nephrotic Syndrome)

👨‍⚕️ Rulan Parekh, MD, The Hospital for Sick Children📍 4 sites📅 Started Jan 2011View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →